Pediatric-onset multiple sclerosis (MS) has been a focus of great interest in recent years.1,2 The hope has been that examining MS in such a young group, without the confounding factors that occur with aging, could shed light on critical environmental and etiopathologic disease factors. In 2006, the National MS Society invested significant funds to establish a National Network of Pediatric MS Centers of Excellence. The goal was to provide multidisciplinary and comprehensive assessment and care to children and adolescents up to age 18 years who have MS and related demyelinating disorders of the central nervous system. Six Pediatric MS Centers of Excellence in the United States have joined to share information and to analyze and publish results as a combined database. This consortium has focused not only on MS but also on acute disseminated encephalomyelitis (ADEM), transverse myelitis/optic neuritis, and neuromyelitis optica (also known as Devic disorder).
Coyle PK. Pediatric Multiple Sclerosis: Just Like Their Elders? Arch Neurol. 2011;68(4):419–421. doi:10.1001/archneurol.2011.49
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.